Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Israel’s Teva Pharmaceutical said in a securities filing Tuesday it has reserved $520 million for an FCPA settlement.
Teva said it is now in “advanced discussions” with the DOJ and SEC.… Continue Reading
ProPublica ran an exposé this week about big bucks for doctors who promote products for drug companies.
A Nashville psychiatrist led the pack, earning more than $1 million during the past four years for promotional talks and consulting for seven drug companies.… Continue Reading
Israel’s Teva Pharmaceutical Industries Limited said it was subpoenaed by the SEC because of potential FCPA compliance problems in Latin America.
Drug-maker Teva, one of Israel’s biggest companies, said in an SEC filing last week it is cooperating with the U.S.… Continue Reading
